IBRN
IBRN
About iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
About iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 XENE | Xenon Pharmaceuticals Inc. | 5.03% | 4.42K | $262.27K |
 ALKS | Alkermes plc | 4.19% | 6.45K | $218.33K |
 PTCT | PTC Therapeutics, Inc. | 4.12% | 2.94K | $214.50K |
 ARGX | argenx SE | 4.09% | 257 | $212.88K |
 AXSM | Axsome Therapeutics, Inc. | 4.04% | 1.14K | $210.70K |
 ARWR | Arrowhead Pharmaceuticals, Inc. | 3.97% | 3.10K | $206.94K |
 CNTA | Centessa Pharmaceuticals plc | 3.94% | 5.19K | $205.31K |
 PRAX | Praxis Precision Medicines, Inc. | 3.92% | 594 | $204.10K |
 SRRK | Scholar Rock Holding Corporation | 3.88% | 4.08K | $201.92K |
 DNTH | Dianthus Therapeutics, Inc. | 3.64% | 2.00K | $189.63K |
 NBIX | Neurocrine Biosciences, Inc. | 3.64% | 1.45K | $189.41K |
 ACAD | ACADIA Pharmaceuticals Inc. | 3.52% | 8.33K | $183.38K |
 BIIB | Biogen Inc. | 3.45% | 1.00K | $179.68K |
 CPRX | Catalyst Pharmaceuticals, Inc. | 3.04% | 6.05K | $158.40K |
 DNLI | Denali Therapeutics Inc. | 3.02% | 7.80K | $157.25K |
 SUPN | Supernus Pharmaceuticals, Inc. | 2.89% | 3.00K | $150.33K |
 EWTX | Edgewise Therapeutics, Inc. | 2.69% | 4.23K | $140.33K |
 DYN | Dyne Therapeutics, Inc. | 2.65% | 6.97K | $138.00K |
 SRPT | Sarepta Therapeutics, Inc. | 2.33% | 5.48K | $121.38K |
 AXGN | AxoGen, Inc. | 1.85% | 2.80K | $96.49K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Canada
Ireland
Netherlands
United Kingdom
Sweden
South Korea
Denmark
China
Switzerland
Japan
Australia
France
Israel
ItalySECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Canada Ireland Netherlands United Kingdom Sweden South Korea Denmark China Switzerland Japan Australia France Israel ItalyHoldings (Top 20)
XENE
Xenon Pharmaceuticals Inc.
ALKS
Alkermes plc
PTCT
PTC Therapeutics, Inc.
ARGX
argenx SE
AXSM
Axsome Therapeutics, Inc.
ARWR
Arrowhead Pharmaceuticals, Inc.
CNTA
Centessa Pharmaceuticals plc
PRAX
Praxis Precision Medicines, Inc.
SRRK
Scholar Rock Holding Corporation
DNTH
Dianthus Therapeutics, Inc.
NBIX
Neurocrine Biosciences, Inc.
ACAD
ACADIA Pharmaceuticals Inc.
BIIB
Biogen Inc.
CPRX
Catalyst Pharmaceuticals, Inc.
DNLI
Denali Therapeutics Inc.
SUPN
Supernus Pharmaceuticals, Inc.
EWTX
Edgewise Therapeutics, Inc.
DYN
Dyne Therapeutics, Inc.
SRPT
Sarepta Therapeutics, Inc.
AXGN
AxoGen, Inc.